These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Effects of amiodarone, cyclosporin A, and PSC 833 on the cytotoxicity of mitoxantrone, doxorubicin, and vincristine in non-P-glycoprotein human small cell lung cancer cell lines. van der Graaf WT; de Vries EG; Timmer-Bosscha H; Meersma GJ; Mesander G; Vellenga E; Mulder NH Cancer Res; 1994 Oct; 54(20):5368-73. PubMed ID: 7923167 [TBL] [Abstract][Full Text] [Related]
7. The multidrug-resistance-reverser verapamil interferes with cellular P-glycoprotein-mediated pumping of daunorubicin as a non-competing substrate. Spoelstra EC; Westerhoff HV; Pinedo HM; Dekker H; Lankelma J Eur J Biochem; 1994 Apr; 221(1):363-73. PubMed ID: 7909520 [TBL] [Abstract][Full Text] [Related]
8. Increased efflux of vincristine, but not of daunorubicin, associated with the murine multidrug resistance protein (MRP). Slapak CA; Martell RL; Terashima M; Levy SB Biochem Pharmacol; 1996 Nov; 52(10):1569-76. PubMed ID: 8937472 [TBL] [Abstract][Full Text] [Related]
9. Cross-resistance to antifolates in multidrug resistant cell lines with P-glycoprotein or multidrug resistance protein expression. van Triest B; Pinedo HM; Telleman F; van der Wilt CL; Jansen G; Peters GJ Biochem Pharmacol; 1997 Jun; 53(12):1855-66. PubMed ID: 9256160 [TBL] [Abstract][Full Text] [Related]
10. Kinetics of daunorubicin transport by P-glycoprotein of intact cancer cells. Spoelstra EC; Westerhoff HV; Dekker H; Lankelma J Eur J Biochem; 1992 Jul; 207(2):567-79. PubMed ID: 1353020 [TBL] [Abstract][Full Text] [Related]
11. Ascorbic acid increases drug accumulation and reverses vincristine resistance of human non-small-cell lung-cancer cells. Chiang CD; Song EJ; Yang VC; Chao CC Biochem J; 1994 Aug; 301 ( Pt 3)(Pt 3):759-64. PubMed ID: 7914401 [TBL] [Abstract][Full Text] [Related]
12. Kinetics of anthracycline efflux from multidrug resistance protein-expressing cancer cells compared with P-glycoprotein-expressing cancer cells. Marbeuf-Gueye C; Broxterman HJ; Dubru F; Priebe W; Garnier-Suillerot A Mol Pharmacol; 1998 Jan; 53(1):141-7. PubMed ID: 9443942 [TBL] [Abstract][Full Text] [Related]
13. Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3. Martell RL; Slapak CA; Levy SB Br J Cancer; 1997; 75(2):161-8. PubMed ID: 9010020 [TBL] [Abstract][Full Text] [Related]
14. Modulator activity of PSC 833 and cyclosporin-A in vincristine and doxorubicin-selected multidrug resistant murine leukemic cells. Lopes EC; Scolnik M; Alvarez E; Hajos SE Leuk Res; 2001 Jan; 25(1):85-93. PubMed ID: 11137565 [TBL] [Abstract][Full Text] [Related]
15. Competitive inhibition by genistein and ATP dependence of daunorubicin transport in intact MRP overexpressing human small cell lung cancer cells. Versantvoort CH; Broxterman HJ; Lankelma J; Feller N; Pinedo HM Biochem Pharmacol; 1994 Sep; 48(6):1129-36. PubMed ID: 7945406 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of idarubicin, daunorubicin, and their C-13 alcohol metabolites to transport-mediated multidrug resistance. Ross DD; Doyle LA; Yang W; Tong Y; Cornblatt B Biochem Pharmacol; 1995 Nov; 50(10):1673-83. PubMed ID: 7503771 [TBL] [Abstract][Full Text] [Related]
17. Correlation between the kinetics of anthracycline uptake and the resistance factor in cancer cells expressing the multidrug resistance protein or the P-glycoprotein. Marbeuf-Gueye C; Ettori D; Priebe W; Kozlowski H; Garnier-Suillerot A Biochim Biophys Acta; 1999 Jul; 1450(3):374-84. PubMed ID: 10395948 [TBL] [Abstract][Full Text] [Related]